chartexchange

PRLD
Prelude Therapeutics Incorporated
stockNASDAQ

Market OpenNov 19, 2026 3:32:19 PM EST
3.23USD-2.121%(-0.07)144,573
3.2100Bid3.2400Ask0.0300Spread
Loading…
Loading…
258.08M
Healthcare
Biotechnology
HQ
Wilmington, DE, USA
Previous Close
$3.30
Beta
1.74
52-Week High
$6.83 2026-08-24
52-Week Low
$1.30 2025-12-03
SMA 50
$3.88
SMA 200
$4.12
Avg. Vol 10D
271,578
Avg. Vol 30D
369,190
Avg. Vol 90D
445,797
Relative Vol
0.39
44.73M
0.5400%
4,774
PRLD Profile

prelude therapeutics incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapies optimized to target the key driver mechanisms in cancers. it is developing prt543 that is in phase 1 clinical trials in select solid tumors and myeloid malignancies in patients who are refractory to or intolerant of established therapies; and prt811, which is in phase 1 clinical trials in solid tumors, including glioblastoma multiforme and primary central nervous system lymphomas. the company is also developing prt1419, a potent and selective inhibitor of the anti-apoptotic protein; prt2527, a potent inhibitor of cdk9 that exhibits high kinome selectivity; prt-sca2 for multiple genomically selected cancers; and prt-k4 for solid tumors. prelude therapeutics incorporated was founded in 2016 and is based in wilmington, delaware.

PRLD Performance
PeriodPriceDateChangeBeta
1W3.522026-11-12-8.38%0.035
1M3.392026-10-19-4.87%2.730
3M5.782026-08-19-44.20%2.105
6M4.272026-05-19-24.47%1.669
1Y1.672025-11-19+93.11%1.743
2Y0.962024-11-19+235.90%—
5Y14.462021-11-19-77.70%1.571
PRLD Stock Summary

Prelude Therapeutics Incorporated (NASDAQ:PRLD) stock price today is $3.23, and today's volume is 144,571. PRLD is down 2.273% today. The 30 day average volume is 369,190. PRLD market cap is $258.08M with 80.03M shares outstanding.